CVS Health is in advanced talks to acquire the home-healthcare company Signify Health for around $8 billion, according to people familiar with the matter. CVS appears to have beat out other heavy hitt...
Tag: Pfizer
CDC’s Walensky Signs Off On Omicron Booster–Here’s When You Can Get One
Topline Rochelle Walensky, the director of the Centers for Disease Control and Prevention, signed off on Moderna and Pfizer/BioNTech’s updated Covid-19 booster shots targeting the virulent omicron var...
Vaccine Stocks Dip: Moderna Sues Pfizer, BioNTech For Patent Infringement
Moderna (MRNA) said Friday it’s suing Pfizer (PFE) and BioNTech (BNTX) for patent infringement, claiming the duo copied its messenger RNA technology to make Covid vaccine Comirnaty. In response,...
Pfizer ‘surprised’ by Moderna COVID-19 vaccine patent lawsuit
Moderna (MRNA) said Friday it is suing Pfizer and BioNTech (PFE/BNTX), alleging the rival drug makers infringed three patents on the technology it used for its mRNA COVID-19 vaccine. In two lawsuits f...
Ups & Downs: Top Pharmaceutical Stocks Post-COVID
Who will be Big Pharma’s winners post-COVID? Getty Images There’s little argument that the COVID-19 pandemic reshaped the world. While families and governments continue to grapple with Omicron v...
Teens’ Protection From Pfizer’s Covid Shot Fades Weeks After Vaccination—But Shot Still Wards Off Serious Illness, Study Finds
Topline The effectiveness of Pfizer and BioNTech’s Covid-19 vaccine in teens fades rapidly in the weeks after vaccination, according to research published Wednesday in JAMA Network Open, a finding tha...
Pfizer Stock Slumps On Litigation Linked to Zantac Heartburn Drug
Updated at 12:17 pm EST Pfizer (PFE) – Get Pfizer Inc. Report shares slumped lower Thursday amid investor concern over potential litigation linked to the popular, but now-discontinued, heartbur...
Pfizer is acquiring Global Blood Therapeutics
Pfizer Inc (NYSE: PFE) has executed a definitive merger agreement with Global Blood Therapeutics Inc (NASDAQ: GBT), whereby Pfizer will acquire the biopharmaceutical corporation dedicated to the deliv...
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
Topline Pfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus latest this month, BioNTech ann...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...
A Recession Is Coming. These Are the Stocks to Hunker Down In.
Eli Salzmann loves nothing better than finding a company that’s a “dog of a stock with no momentum” but on the verge of better days. At its core, that is what value investing is all about. Over the co...
Moderna CEO: No ‘Crazy’ Deals. We’re Giving Cash to Shareholders.
Text size Moderna CEO Stephane Bancel says his company will keep returning cash to investors until it finds a better way of creating value. Jason Alden/Bloomberg Moderna ’s CEO is feeling no pressure ...
Moderna’s Earnings Are Wednesday. Here’s What to Expect.
Text size Moderna is developing two vaccines for the fall, one for the U.S. and the other for international markets. Sean Gallup/Getty Images As the U.S. prepares for a broad Covid-19 booster campaign...
Pfizer Stock Dives As Covid-Driven Beat Doesn’t Translate In Guidance
Pfizer stock tumbled Thursday after delivering a second-quarter earnings beat almost entirely on the back of its Covid vaccine and antiviral pill. X The two products, Comirnaty and Paxlovid, brought i...
Pfizer Stock Crashes Into 50-Day Line As CureVac Squares Off With Patent Suit
Pfizer stock crashed into its 50-day line Tuesday after German biotech CureVac (CVAC) sued its Covid vaccine partner, BioNTech, for patent infringement. X CureVac says it filed a lawsuit in the German...
Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.
Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges
Shares of Roivant Sciences Ltd. ROIV, -2.30% shot up 10.0% in premarket trading Tuesday, after the biopharmaceutical company and drug giant Pfizer Inc. PFE, +0.56% unveiled Priovant Therapeutics, a bi...
Kroger, S&P Global, Lockheed Martin, Pfizer, Matson
Kroger’s Board of Directors approved a dividend increase from $0.84 to $1.04 per year. The next quarterly dividend of 26 cents per share will be paid on September 1, 2022, to shareholders of rec...